Dechra launches new vitamin K1 tablet therapy

Dechra Veterinary Products has announced the launch of a new range of vitamin K1 50mg tablets, for the treatment of anticoagulant poisoning following exposure to rodenticides.

The tablets were only previously available as a special import certificate product following Dechra's acquisition of Eurovet, but have now been approved for sale in the UK.

This product represents a key tool in the treatment of potential and accidental exposures to anticoagulant rat poisoning among domestic pets, particularly in dogs, as it helps to assist with blood clotting.

The Veterinary Poisons Information Service has received more than 6,000 calls so far this year to its helpline regarding cases of poisoning of this kind, making it the second most common type of query received by the service.

Dechra Veterinary Products brand manager Carol Morgan said: "With the launch of these tablets, veterinary professions will be able to have a ready supply of vitamin K to hand. We would recommend that all practices consider stocking this product."

Earlier this month, the company announced that it has experienced significant growth in the first half of 2013, thanks in large part to the positive impact of its Eurovet acquisition.